Adverum Biotechnologies (ADVM) Short Interest Ratio & Short Volume → Biden replacement revealed? (From Paradigm Press) (Ad) Free ADVM Stock Alerts $11.34 +0.19 (+1.70%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Adverum Biotechnologies Short Interest DataCurrent Short Volume890,000 sharesPrevious Short Volume648,500 sharesChange Vs. Previous Month+37.24%Dollar Volume Sold Short$12.58 millionShort Interest Ratio / Days to Cover3.4Last Record DateMarch 31, 2024Outstanding Shares20,755,000 sharesFloat Size14,970,000 sharesShort Percent of Float5.95%Today's Trading Volume138,898 sharesAverage Trading Volume239,898 sharesToday's Volume Vs. Average58% Short Selling Adverum Biotechnologies ? Sign up to receive the latest short interest report for Adverum Biotechnologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADVM Short Interest Over TimeADVM Days to Cover Over TimeADVM Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Adverum Biotechnologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024890,000 shares $12.58 million +37.2%6.0%3.4 $14.14 3/15/2024648,500 shares $11.02 million -88.1%4.3%2.8 $17.00 2/29/20245,430,000 shares $10.75 million +35.4%N/A3 $1.98 2/15/20244,010,000 shares $8.02 million +228.7%4.5%2.4 $2.00 1/31/20241,220,000 shares $1.28 million -26.1%1.4%0.9 $1.05 1/15/20241,650,000 shares $1.40 million -2.4%1.9%4.4 $0.85 Get the Latest News and Ratings for ADVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adverum Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,690,000 shares $1.27 million +7.6%1.9%5.6 $0.75 12/15/20231,570,000 shares $1.28 million +5.4%1.8%5.8 $0.82 11/30/20231,490,000 shares $1.20 million No Change1.7%5.9 $0.81 11/15/20231,490,000 shares $1.31 million +10.4%1.7%6.4 $0.88 10/31/20231,350,000 shares $1.21 million +4.7%1.5%5.6 $0.90 10/15/20231,290,000 shares $1.26 million +15.2%1.5%4.6 $0.98 9/30/20231,120,000 shares $1.68 million -16.4%1.3%3.2 $1.50 9/15/20231,340,000 shares $2.09 million +20.7%1.5%3.1 $1.56 8/31/20231,110,000 shares $1.93 million +5.7%1.3%2.2 $1.74 8/15/20231,050,000 shares $1.88 million +10.5%1.2%1.9 $1.79 7/31/2023950,000 shares $2.07 million -13.6%1.0%1.8 $2.18 7/15/20231,100,000 shares $2.21 million -17.9%1.1%2.1 $2.01 6/30/20231,340,000 shares $2.13 million -14.1%1.4%2.9 $1.59 6/15/20231,560,000 shares $2.28 million +5.4%1.6%3.5 $1.46 5/31/20231,480,000 shares $1.82 million +2.8%1.5%3.4 $1.23 5/15/20231,440,000 shares $1.19 million -0.7%1.5%3.6 $0.83 4/30/20231,450,000 shares $1.14 million -4.0%1.6%3.4 $0.78 4/15/20231,510,000 shares $1.27 million -2.0%1.7%3.2 $0.84 3/31/20231,540,000 shares $1.10 million -3.1%1.7%3.5 $0.72 3/15/20231,590,000 shares $1.30 million +1.9%1.8%3 $0.82 2/28/20231,560,000 shares $1.12 million No Change1.7%3.3 $0.72 2/15/20231,560,000 shares $970,788.00 -0.6%1.7%2.9 $0.62 1/31/20231,570,000 shares $1.02 million -12.3%1.7%2.7 $0.65 1/15/20231,790,000 shares $1.22 million -8.2%2.0%3.2 $0.68 12/30/20221,950,000 shares $1.13 million -8.9%2.1%3.5 $0.58 12/15/20222,140,000 shares $1.35 million -11.9%2.4%3.9 $0.63 11/30/20222,430,000 shares $1.63 million No Change2.7%4.8 $0.67 11/15/20222,430,000 shares $1.70 million -5.8%2.7%4.8 $0.70 10/31/20222,580,000 shares $2.23 million -2.6%2.9%5.8 $0.87 10/15/20222,650,000 shares $2.46 million -0.4%2.9%6 $0.93 9/30/20222,660,000 shares $2.53 million +7.7%3.0%3.8 $0.95 9/15/20222,470,000 shares $2.72 million No Change2.7%2.3 $1.10 8/31/20222,470,000 shares $2.87 million -4.6%2.7%2.1 $1.16 8/15/20222,590,000 shares $3.65 million -15.4%2.9%2.1 $1.41The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him ADVM Short Interest - Frequently Asked Questions What is Adverum Biotechnologies' current short interest? Short interest is the volume of Adverum Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 890,000 shares of ADVM short. 5.95% of Adverum Biotechnologies' shares are currently sold short. Learn More on Adverum Biotechnologies' current short interest. What is a good short interest ratio for Adverum Biotechnologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADVM shares currently have a short interest ratio of 3.0. Learn More on Adverum Biotechnologies's short interest ratio. Which institutional investors are shorting Adverum Biotechnologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adverum Biotechnologies: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Adverum Biotechnologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.95% of Adverum Biotechnologies' floating shares are currently sold short. Is Adverum Biotechnologies' short interest increasing or decreasing? Adverum Biotechnologies saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 890,000 shares, an increase of 37.2% from the previous total of 648,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adverum Biotechnologies' float size? Adverum Biotechnologies currently has issued a total of 20,750,000 shares. Some of Adverum Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adverum Biotechnologies currently has a public float of 14,970,000 shares. How does Adverum Biotechnologies' short interest compare to its competitors? 5.95% of Adverum Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Adverum Biotechnologies: Coherus BioSciences, Inc. (20.66%), Sutro Biopharma, Inc. (3.86%), X4 Pharmaceuticals, Inc. (7.34%), Compass Therapeutics, Inc. (1.97%), Elevation Oncology, Inc. (12.58%), Acumen Pharmaceuticals, Inc. (2.88%), Innate Pharma S.A. (0.10%), Opthea Limited (0.22%), Cardiff Oncology, Inc. (7.63%), Kodiak Sciences Inc. (3.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Adverum Biotechnologies stock? Short selling ADVM is an investing strategy that aims to generate trading profit from Adverum Biotechnologies as its price is falling. ADVM shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adverum Biotechnologies? A short squeeze for Adverum Biotechnologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADVM, which in turn drives the price of the stock up even further. How often is Adverum Biotechnologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADVM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Coherus BioSciences Short Interest Sutro Biopharma Short Interest X4 Pharmaceuticals Short Interest Compass Therapeutics Short Interest Elevation Oncology Short Interest Acumen Pharmaceuticals Short Interest Innate Pharma Short Interest Opthea Short Interest Cardiff Oncology Short Interest Kodiak Sciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADVM) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends